Using DNA sequencing to help doctors and pharmaceutical companies personalize treatments for disease has netted a South Carolina startup a small seed round of capital. According to a recent SEC filing, Selah Genomics has raised at least $300,000 and could raise another $600,000 more. CEO Michael Bolick could not be reached by email to comment. […]
Now that next-generation DNA sequencing is fast enough, cheap enough and commercially available, the next challenging for innovators is finding ways to effectively apply it to everyday medicine outside of the research lab. Mayo Clinic and personalized medicine firm Cancer Genetics Inc. (NASDAQ:CGIX) have formed a new company to do just that. OncoSpire Genomics, announced […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
When a company sets out to enter a market inhabited by heavyweights like LabCorp and Quest Diagnostics, it better have something good. Good Start Genetics has applied next-generation DNA sequencing to existing knowledge and testing methods to come up with what it thinks is that something special. The company has developed a series of […]
Mayo Clinic announced Tuesday that it is partnering with Silicon Valley Biosystems, a California diagnostics company, to provide better genomics diagnostics and interpretation. Described as a “strategic relationship,” the financial terms of the partnership weren’t disclosed. Under the agreement, SV Bio will provide its genome interpretation solution services and clinical decision support services to Mayo. […]